Zealand Pharma A/S (Zealand Pharma A/S) Total Assets : $522.87 Mil (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Zealand Pharma A/S Total Assets?

Zealand Pharma A/S's Total Assets for the quarter that ended in Mar. 2024 was $522.87 Mil.

During the past 12 months, Zealand Pharma A/S's average Total Assets Growth Rate was 365.90% per year. During the past 3 years, the average Total Assets Growth Rate was -11.70% per year. During the past 5 years, the average Total Assets Growth Rate was 31.80% per year. During the past 10 years, the average Total Assets Growth Rate was 22.70% per year.

During the past 13 years, Zealand Pharma A/S's highest 3-Year average Total Assets Growth Rate was 117.00%. The lowest was -31.30%. And the median was 25.75%.

Total Assets is connected with ROA %. Zealand Pharma A/S's annualized ROA % for the quarter that ended in Mar. 2024 was -32.82%. Total Assets is also linked to Revenue through Asset Turnover. Zealand Pharma A/S's Asset Turnover for the quarter that ended in Mar. 2024 was 0.01.

Zealand Pharma A/S Total Assets Historical Data

The historical data trend for Zealand Pharma A/S's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zealand Pharma A/S Total Assets Chart

Zealand Pharma A/S Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

229.19

288.12

314.18

219.26

289.69

Zealand Pharma A/S Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															192.82	298.27	311.33	289.69	522.87

Zealand Pharma A/S Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Zealand Pharma A/S's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	233.048	+	56.645
	=	289.69

Zealand Pharma A/S's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	413.709	+	109.164
	=	522.87

Zealand Pharma A/S (OTCPK:ZLDPF) Total Assets Explanation

Total Assets is connected with ROA %.

Zealand Pharma A/S's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	-133.324	/	( (289.693	+	522.873)	/ 2 )
	=	-133.324	/	406.283
	=	-32.82 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Zealand Pharma A/S's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	2.2	/	( (289.693	+	522.873)	/ 2 )
=	2.2	/	406.283
=	0.01

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Zealand Pharma A/S Total Assets Related Terms

Thank you for viewing the detailed overview of Zealand Pharma A/S's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Zealand Pharma A/S (Zealand Pharma A/S) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zealand Pharma A/S (OTCPK:ZLDPF) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

ZEALc:UK 0NZU:UK ZEAL:Denmark 22Z:Germany

Address

Sydmarken 11, Soborg, DNK, DK-2860

Website

https://www.zealandpharma.com

Zealand Pharma A/S is a biotechnology company. It is focused on the discovery, design, and development of peptide-based medicines. The company's product pipeline includes three product candidates in clinical development: glepaglutide, which is being developed to treat short bowel syndrome or SBS; dasiglucagon formulated for use in a dual-hormone artificial pancreas system for diabetes management; and dasiglucagon for use in the treatment of congenital hyperinsulinism. The company has out-licensed a peptide program to Boehringer Ingelheim that has been moved ahead into early clinical development: a once-weekly novel dual-acting GLP-1/glucagon agonist for the treatment of obesity and/or Type 2 diabetes.